Publications

Detailed Information

Control of Host Lipid Metabolism by Gut Commensal Bacteroides acidifaciens

DC Field Value Language
dc.contributor.advisor유상렬-
dc.contributor.author양진영-
dc.date.accessioned2017-07-13T17:37:49Z-
dc.date.available2017-10-23T07:47:19Z-
dc.date.issued2015-08-
dc.identifier.other000000066730-
dc.identifier.urihttps://hdl.handle.net/10371/120981-
dc.description학위논문 (박사)-- 서울대학교 대학원 : 협동과정 농업생물공학전공, 2015. 8. 유상렬.-
dc.description.abstractIn human, the composition of gut commensal bacteria is closely correlated with obesity through the modulation of microbial community and host immunity. However, a direct correlation between certain commensal bacteria and host metabolism remains unclear. In this study, I found significantly reduced body weight and fat mass overtime in conditional knock-out mice with CD11c+ cells with specific deletion of autophagy-related gene 7 (Atg7ΔCD11c) when compared with littermate control (Atg7f/f) mice. Interestingly, the level of insulin in serum from Atg7ΔCD11c mice having low body weight and fat mass was increased, but simultaneously the glucose in serum was low resulting insulin resistance improved. When mice shared commensal bacteria by co-housing or feces transfer experiments, body weight and fat mass were similar in both Atg7f/f and Atg7ΔCD11c mice, indicating that commensal bacteria is closely related to lipid metabolism. By pyrosequencing analysis, Bacteroides acidifaciens, one of the commensal bacteria isolated from mouse cecum, were significantly increased (>5%) in feces of Atg7ΔCD11c mice compared with those of control Atg7f/f mice. However, the ratio of B. sartorii, belonging to the Bacteroides genus, was shown a similar level between Atg7ΔCD11c and Atg7f/f mice. To clarify the efficacy of B. acidifaciens I selected in pyrosequencing analysis to control the host metabolism, I orally administrated these commensal bacteria to C57BL/6 (B6) mice. Most interestingly, while wild-type B6 mice fed with B. sartorii were shown similar body weight, B6 mice fed B. acidifaciens daily for 10 weeks were significantly lose body weight and fat mass than control, even though both groups consumed the same amount of food (i.e., normal chow diet or high-fat diet). Enhanced insulin sensitivity was also detected in serum of B6 mice following B. acidifaciens administration by glucose tolerance test (GTT) and insulin tolerance test (ITT). Of note, predominant expression of peroxisome proliferator-activated receptor alpha (PPARα), a key molecule of fat consumption through β-oxidation, was consistently found in the adipose tissues of Atg7ΔCD11c mice, wild-type B6 mice transferred with fecal microbiota of Atg7ΔCD11c mice, and B. acidifaciens-fed wild-type B6 mice. However, the expression levels of PPARα were not shown any significant difference between group in liver and small intestine. Capillary electrophoresis time-of-flight mass spectrometry (CE-TOFMS) assay also revealed that the enhanced level of cholate, a primary bile acid, was detected in feces of B6 mice fed with B. acidifaciens for 10 weeks. In addition, the bile acid-responsive G protein-coupled receptor TGR5 was significantly activated in adipose tissues of B6 mice following B. acidifaciens short-term feeding, indicating that administration of B. acidifaciens resulted in activation of fat oxidation through the bile acid-TGR5-PPARα axis in adipose tissues, possibly leading to higher energy expenditure. B. acidifaciens also inactivated dipeptidyl peptidase-4 (DPP-4) in the gut and subsequently increased glucagon-like peptide-1 (GLP-1), which may contribute to glucose homeostasis. These findings strongly suggest that B. acidifaciens plays an active role in the prevention and therapy of metabolic diseases such as diabetes and obesity.-
dc.description.tableofcontentsContents

Abstract …………………………………………………………………… I
Contents ………………………………………………………………IV
List of Tables ………………………………………………………IX
List of Figures ……………………………………………………X

Chapter I. General Introduction ……………………………………… 1
I-1. Gastrointestinal immunity ……………………………………… 2
I-1-1. Introduction …………………………………………… 2
I-1-2. Gastrointestinal defense mechanism………………………… 2
I-1-2-1. Secretory immunoglobulin A (sIgA) ……………… 2
I-1-2-2. Intestinal epithelial cells (IECs) ……………………… 3
I-2. Autophagy...……………………………………………………… 5
I-2-1. Introduction…………………………………………………. 5
I-2-2. The autophagic pathway………………………………… 5
I-3. Gut microbiota……………………………………………… 7
I-3-1. Introduction…………………………………………………. 7
I-3-2. The role of intestinal commensal microbes…………… 8
I-4. Obesity ………………………………………………………… 9
I-4-1. Introduction ………………………………………………… 9
I-4-2. Commensal microbiota in host metabolism………………… 9
I-4-3. Application of commensal microbiota: Bacteriotherapy.…… 10
I-5. Objectives…………………………………………………… 11
I-6. References ………………………………………………… 12

Chapter II. Specific deletion of autophagy-related gene (atg7) in CD11c+ cells alter murine gut microbiota..………………………………… 17
II-1. Introduction …….......................................................................... 18
II-2. Materials and Methods …………………………………… 21
II-2-1. Ethics statement ………………………………………… 21
II-2-2. Mice and bacteria strains ……………………………… 21
II-2-3. Bacteria culture ………………………………………… 22
II-2-4. Glucose tolerance test (GTT) and
insulin tolerance test (ITT) ……………………………… 22
II-2-5. Fecal microbiota transplantation……………………… 23
II-2-6. Magnetic resonance imaging (MRI) analysis………… 23
II-2-7. Gas chromatography mass spectrometry (GC-MS)
measurement…………………………… 24
II-2-8. Fluorescence in situ hybridization (FISH) analysis … 25
II-2-9. Cytokine levels in serum………………………………… 26
II-2-10. Histology………………………………………………… 26
II-2-11. Bacterial antigen preparation and B. acidifaciens-specific ELISA…………………………………………………… 26
II-2-12. 454 pyrosequencing analysis…………………………… 27
II-2-13. Real-time PCR for tissues……………………….……… 28
II-2-14. Analysis of metabolic parameters..……………………… 29
II-2-15. Statistics………………………………………………… 29
II-3. Results ...………………………………………………………… 31
II-3-1. Atg7ΔCD11c mice showed lean phenotypes with reduced body weight and fat mass ………………………………… 31
II-3-2. Atg7ΔCD11c mice shown lean phenotypes were not related with inflammation ……………………………………………… 39
II-3-3. Insulin sensitivity was improved in Atg7ΔCD11c mice………42
II-3-4. Low levels of short-chain fatty acids (SCFAs) in the feces of Atg7ΔCD11c mice…………………………………… 45
II-3-5. Commensal bacteria are associated with the lean phenotype of aged Atg7ΔCD11c mice……………………………… 48
II-3-6. Expansion of Bacteroides acidifaciens in the feces of
Atg7ΔCD11c mice …………………………………………… 53
II-3-7. Characterization of CD11c positive cells as phagocytes and
antigen-presenting cells against Bacteroides acidifaciens........59
II-4. Discussion ...…………………………………………………… 62
II-5. References..…………………………………………………… 67


Chapter III. Gut commensal Bacteroides acidifaciens improves insulin
sensitivity and prevents obesity in mice…………………………… 72
III-1. Introduction .………………………………………………… 73
III-2. Materials and Methods ……………………………………… 75
III-2-1. Ethics statement……………………… ………………… 75
III-2-2. Mice and bacteria strains ………………………………… 75
III-2-3. Bacteria culture and administration……………………… 76
III-2-4. Magnetic resonance imaging (MRI) analysis………… 76
III-2-5. MRI data analysis………………………………………… 77
III-2-6. Fluorescence in situ hybridization (FISH) analysis ……… 78
III-2-7. Histology ………………………………………………… 78
III-2-8. Real-time PCR for tissues……………………………… 79
III-2-9. Analysis of metabolic parameters……………………… 79
III-2-10. Measurement of glucagon-like peptide-1 (GLP-1)....…… 81
III-2-11. Measurement of depeptidyl peptidase-4 (DPP-4)……… 81
III-2-12. Comprehensive laboratory animal monitoring system
(CLAMS) ……………………………………………… 82
III-2-13. Capillary electrophoresis time-of-flight mass spectrometry
(CE-TOFMS) measurement …………………………… 82
III-2-14. Statistics ………………………………………………… 83
III-3. Results ...……………………………………………………… 84
III-3-1. The scheme of oral administration with B. acidifaciens…84
III-3-2. Oral administration of B. acidifaciens leads to lean phenotypes in NCD- or HFD-fed B6 mice…………………………… 87
III-3-3. Increased insulin levels in serum and energy expenditure were detected in B. acidifaciens-fed B6 mice..…………………… 93
III-3-4. Mice having lean phenotypes exhibited enhanced peroxisome
proliferator activated receptor (PPAR) α expression in their
adipose tissues ……………………………………………… 100
III-3-5. B. acidifaciens modulates GLP-1 production by regulating
DPP4 enzyme in small intestine …………………………... 107
III-4. Discussion ...……………………………………………… 110
III-5. References ………………………………………………… 114

Chapter IV. Overall Conclusion ........... 118
IV-1. Gut commensal Bacteroides acidifaciens expanded in Atg7ΔCD11c
mice improves insulin sensitivity and prevents obesity……… 119
IV-2. Proposed models of lean bug B. acidifaciens to protect host against insulin resistance and obesity. …………………… 124



국문 초록 .…………………………………………………………… 126

List of Tables

Table 3.1. Primers used in the present study……………………80

List of Figures

Figure 2.1. Morphological characteristics of Atg7ΔCD11c mice…33
Figure 2.2. Inflammatory phenomenon in serum, adipose tissue, and intestinal area………………………………………40
Figure 2.3. Glucose / insulin levels in serum of Atg7ΔCD11c mice.....43
Figure 2.4. Orthogonal partial least squares discriminate analysis (OPLS-DA) in feces ………………………………46
Figure 2.5. Representative photos, body / fat weight, and glucose / insulin levels of feces-transferred mice……………49
Figure 2.6. Pyrosequencing analysis in feces and confocal images of Bacteroides acidifaciens …………………………55
Figure 2.7. Colony forming units (CFUs) of B. acidifaciens, antibodies detection by Enzyme-linked immunosorbent assay (ELISA), and activation of co-stimulatory molecules by FACS analysis ………………………60

Figure 3.1. Confocal images of B.acidifaciens in colon and feces....85
Figure 3.2. Representative photos, magnetic resonance imaging (MRI) analysis, and body / fat weight, and histologic analysis of adipose tissues ……………………………88
Figure 3.3. Glucose / insulin levels, GTT / ITT analysis, and comprehensive laboratory animal monitoring system (CLAMS) analysis …...………………………………94
Figure 3.4. mRNA expression levels of fatty acid synthesis,
β-oxidation , and thermogenesis by RT-PCR ………102
Figure 3.5. B. acidifaciens (BA) can regulate intestinal dipeptidal peptidase-4 (DPP-4) secretion and subsequently
induce glucagon-like peptide 1 (GLP-1) production
in B6 mice..................................................................... 108

Figure 4.1. The scheme of this study ……………………… 124
-
dc.formatapplication/pdf-
dc.format.extent6048452 bytes-
dc.format.mediumapplication/pdf-
dc.language.isoen-
dc.publisher서울대학교 대학원-
dc.subjectBacteroides acidifaciens-
dc.subjectinsulin sensitivity-
dc.subjectproliferate peroxisome-activated receptor (PPARα)-
dc.subjectglucagon-like peptide-1 (GLP-1)-
dc.subjectbile acids-
dc.subject.ddc660-
dc.titleControl of Host Lipid Metabolism by Gut Commensal Bacteroides acidifaciens-
dc.typeThesis-
dc.description.degreeDoctor-
dc.citation.pagesXI, 128-
dc.contributor.affiliation농업생명과학대학 협동과정 농업생물공학전공-
dc.date.awarded2015-08-
Appears in Collections:
Files in This Item:

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share